Banks Apothecary

91


Banks Apothecary is listed in the Vitamins & Food Supplements category in Philadelphia, Pennsylvania. Displayed below are the social networks for Banks Apothecary which include a Facebook page and a Twitter account. The activity and popularity of Banks Apothecary on these social networks gives it a ZapScore of 91.

Contact information for Banks Apothecary is:
1335 W Tabor Rd
Philadelphia, PA 19141
(215) 927-6700
Do you own or manage this business? Click here to claim the Banks Apothecary listing and add social networks, logos, descriptions and more.

Banks Apothecary Contact Information:

Social Posts for Banks Apothecary


Bank's Apothecary went international #tallestBuildingInTheWorld https://t.co/z8ddvAsWy1

Now it's easier to contact Bank's Apothecary.


Did you know? Bank's Apothecary is an IN-NETWORK Specialty pharmacy provider for 98% of all Medicare/Medicaid insurances in Pennsylvania!


Did you know? Bank's Apothecary is an IN-NETWORK Specialty pharmacy provide for HUMANA - Medicare, Medicaid and commercial insurances.

Bank's Apothecary at Pittsburgh International Airport.
Hey Folks! Have you ran into this sign at the Pittsburgh airport? Are you with UPMC or thinking of joining? Guess which pharmacy is in their specialty network? Bank's Apothecary!!!


Have you ran into this sign at the airport? Guess which pharmacy is in their specialty network? Bank's Apothecary!! https://t.co/4vJghqWxC8


Guess where we are tonight ? In the heart of Steelers country! https://t.co/MykepRBjgs

Bank's Apothecary in Feasterville-Trevose, Pennsylvania.
Check us out in the October issue of Specialty Pharmacy Times!

Bank's Apothecary Now Dispensing FDA Approved Medication ENTYVIO! Bank's Apothecary continuously strives to deliver the highest quality of healthcare service in the industry. Our goal is to expand access to patient care and medication services. .Bank's Apothecary wants our patients to have the newest line of medication therapies available to them to treat these illness and give them quality specialty pharmacy service. Bank's is pleased to announce that we are part of a select group of highly vetted pharmacies that now have access to the limited distribution drug (LDD) Entivio. For more information on the medicaiton. Bank's Apothecary is now able to provide FDA approved medication Entyvio (vedolizumab) for ulcerative colitis (UC) and Crohn's disease (CD). Entyvio is a prescription medicine used in adults with moderately to severely active ulcerative colitis (UC) when certain other UC medicines have not worked well or cannot be tolerated. Entyvio may help to: begin reducing some symptoms, induce and maintain remission, reduce or stop the use of corticosteroids, and improve the way the lining of your large intestine looks to your healthcare provider. Entyvio is a prescription medicine used in adults with moderately to severely active Crohn's disease (CD) when certain other CD medicines have not worked well or cannot be tolerated. Entyvio may help to: begin reducing some symptoms, achieve remission, and reduce or stop the use of corticosteroids Entyvio is given through intravenous infusion in your arm. You will be given a starting regimen of 3 Entyvio infusions, and then treatments are given every 8 weeks to help with disease control. It is administered by a healthcare provider, either at your healthcare provider's office or at an infusion center. Entyvio is manufactured by Takeda Pharmaceutical America, Inc. https://www.entyvio.com/

Bank's Apothecary continuously strives to deliver the highest quality of healthcare service in the industry. Our goal is to expand access to patient care and medication services. .Bank's Apothecary wants our patients to have the newest line of medication therapies available to them to treat these illness and give them quality specialty pharmacy service. Bank's is pleased to announce that we are part of a select group of highly vetted pharmacies that now have access to the limited distribution drug (LDD) Entivio. Now Dispensing FDA Approved Medication ENTYVIO Bank's Apothecary is now able to provide FDA approved medication Entyvio (vedolizumab) for ulcerative colitis (UC) and Crohn's disease (CD). Entyvio is a prescription medicine used in adults with moderately to severely active ulcerative colitis (UC) when certain other UC medicines have not worked well or cannot be tolerated. Entyvio may help to: begin reducing some symptoms, induce and maintain remission, reduce or stop the use of corticosteroids, and improve the way the lining of your large intestine looks to your healthcare provider. Entyvio is a prescription medicine used in adults with moderately to severely active Crohn's disease (CD) when certain other CD medicines have not worked well or cannot be tolerated. Entyvio may help to: begin reducing some symptoms, achieve remission, and reduce or stop the use of corticosteroids Entyvio is given through intravenous infusion in your arm. You will be given a starting regimen of 3 Entyvio infusions, and then treatments are given every 8 weeks to help with disease control. It is administered by a healthcare provider, either at your healthcare provider's office or at an infusion center. Entyvio is manufactured by Takeda Pharmaceutical America, Inc.